New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 10, 2014
09:06 EDTNUVA, THOR, ELGX, BSX, STJ, DGX, ABCO, FLDM, CMNPiper Jaffray's technical analyst holds an analyst/industry conference call
Technical Analyst Johnson provides a technical review of the firm's Medical Technology covered universe ahead of 4Q results on an Analyst/Industry conference call to be held on January 10 at 10 am.
Sign up for a free trial to see the rest of the stories you've been missing.
December 1, 2015
09:01 EDTBSXNevro price target raised to $78 from $65 at JMP Securities
Subscribe for More Information
08:45 EDTBSXNevro more attractive takeover target after patent news, says Sterne Agee CRT
Subscribe for More Information
06:39 EDTBSXNevro patent case win removes possible overhang, says JPMorgan
Subscribe for More Information
November 30, 2015
16:19 EDTBSXBoston Scientific gets FDA appproval, CE Mark for thrombectomy catheter
Subscribe for More Information
16:13 EDTBSXUSPTO denies inter partes review of of Nevro patent
Subscribe for More Information
08:03 EDTSTJSt. Jude launches Proclaim Elite in Europe
Subscribe for More Information
07:16 EDTSTJSt. Jude Medical management to meet with Deutsche Bank
Subscribe for More Information
06:31 EDTNUVAInvuity names Greg Lucier Chairman of the Board
Invuity (IVTY) announced that life sciences industry luminary Gregory Lucier has been appointed to the role of Chairman of its Board, effective December 31, 2015. Lucier, who is the CEO of Nuvasive (NUVA), has served on the Invuity board since October 2014. He will take the place of Gregory Brown, who will resign from the Board effective December 31, 2015.
November 19, 2015
16:43 EDTBSXBoston Scientific receives CE Mark for next generation WATCHMAN FLX
Boston Scientific announced that the first implants of the WATCHMAN FLX Left Atrial Appendage Closure, or LAAC, Device - the latest generation of the WATCHMAN Device - occurred in Europe following CE mark approval.
10:42 EDTBSXLeerink medical devices analyst holds an analyst/industry conference call
Subscribe for More Information
08:45 EDTELGXEndologix to present 'positive' Nellix clinical data at VEITH Symposium
Subscribe for More Information
08:02 EDTSTJSt. Jude Medical announces FDA approval of Proclaim Elite SCS system
Subscribe for More Information
07:32 EDTELGXCanaccord to hold a forum
Subscribe for More Information
November 18, 2015
16:04 EDTELGXEndologix, TriVascular announce early termination of HSR waiting period
Subscribe for More Information
10:01 EDTELGXEndologix to host investor meeting
Investor meeting to be held in New York on November 19 at 6 pm. Webcast Link
07:41 EDTELGXEndologix announces start of physician-initiated registry of Nellix EVAS System
Endologix announced the start of a physician-initiated registry of the Nellix EndoVascular Aneurysm Sealing System, or Nellix EVAS System, used with aortic branch stent grafts for the treatment of patients with complex abdominal aortic aneurysms, or AAAs. The registry, to be conducted outside of the United States, will be called the ASCEND Registry. The primary investigators are Andrew Holden, MD, Associate Professor of Radiology at Auckland Hospital; and Professor Matthew Thompson, MD, Professor of Vascular Surgery, St. Georges Vascular Institute, London. The Nellix System received CE Mark in 2013 for the treatment of patients with infrarenal AAAs. The Nellix System is an investigational device in the United States.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use